sglt2 inhibitor glp 1 agonist combination Combining GLP-1 Receptor Agonists and Inhibitors in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique | Diabetes Therapy Practical Considerations and Rationale for
Description
The Precision Peptide Genetic Test reveals predispositions in key GLP-1 pathway genesGIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313that may correlate with efficacy and tolerance in clinical studies
DPP-4 inhibitors have a half-life of 12.4 to 24 hours and are dosed once daily
doi: 10.1056/NEJMoa2107519 [DOI] [PubMed] [Google Scholar] 30.Frias JP, Nauck MA, Van J, et al
61% for insulin degludec
This study has some limitations
